open access

Vol 13, No 3 (2009)
Prace oryginalne
Published online: 2009-05-11
Get Citation

The assessment of C-reactive protein concentration in serum of patients with hypertension and hyperhomocysteinemia

Aleksandra Baszczuk, Zygmunt Kopczyński, Danuta Pupek-Musialik, Małgorzata Czeryba, Jarosław Kopczyński, Maciej Cymerys, Anna Thielemann
Nadciśnienie tętnicze 2009;13(3):167-174.

open access

Vol 13, No 3 (2009)
Prace oryginalne
Published online: 2009-05-11

Abstract


Background Currently, the opinion that endothelial dysfunction and inflammatory process influences the development of hypertension is widely accepted. The aim of this work was to evaluate the concentration of high sensitive C-reactive protein (hsCRP) and to investigate the relationship between hsCRP level and hyperhomocysteinemia in serum of hypertensive patients.
Material and methods The survey was carried out in hsCRP sample of 56 patients with hypertension. The control group consisted of 38 subjects found to be healthy. The homocysteine concentration in the serum was measured with immune-fluorescent method (FPIA), with the use of Abbott tests. The levels of hsCRP were assessed by immune-turbidimetric assay based on the Siemens tests.
Results Our research has shown that the average plasma concentration of homocysteine is 10.70 μmol/l in patients with primary hypertension and 9.60 μmol/l in healthy subjects. The average plasma concentration of hsCRP in patients with primary hypertension is statistically higher in comparison to the control group (2.93 vs. 1.55 mg/l). Patients with hyperhomocysteinemia showed higher concentrations of hsCRP than healthy subjects and patients with normohomocysteinemia. However, the correlation between the C-reactive protein concentration and the homocysteine level is not statistically significant.
Conclusion The elevated levels of serum hsCRP concentration in patients with primary hypertension suggest the inflammatory process developing in the blood vessels’ walls. That process is more intensive in patients with hyperhomocysteinemia because they have higher serum level of C-reactive protein.

Abstract


Background Currently, the opinion that endothelial dysfunction and inflammatory process influences the development of hypertension is widely accepted. The aim of this work was to evaluate the concentration of high sensitive C-reactive protein (hsCRP) and to investigate the relationship between hsCRP level and hyperhomocysteinemia in serum of hypertensive patients.
Material and methods The survey was carried out in hsCRP sample of 56 patients with hypertension. The control group consisted of 38 subjects found to be healthy. The homocysteine concentration in the serum was measured with immune-fluorescent method (FPIA), with the use of Abbott tests. The levels of hsCRP were assessed by immune-turbidimetric assay based on the Siemens tests.
Results Our research has shown that the average plasma concentration of homocysteine is 10.70 μmol/l in patients with primary hypertension and 9.60 μmol/l in healthy subjects. The average plasma concentration of hsCRP in patients with primary hypertension is statistically higher in comparison to the control group (2.93 vs. 1.55 mg/l). Patients with hyperhomocysteinemia showed higher concentrations of hsCRP than healthy subjects and patients with normohomocysteinemia. However, the correlation between the C-reactive protein concentration and the homocysteine level is not statistically significant.
Conclusion The elevated levels of serum hsCRP concentration in patients with primary hypertension suggest the inflammatory process developing in the blood vessels’ walls. That process is more intensive in patients with hyperhomocysteinemia because they have higher serum level of C-reactive protein.
Get Citation

Keywords

hypertension; endothelium; C-reactive protein; homocysteine

About this article
Title

The assessment of C-reactive protein concentration in serum of patients with hypertension and hyperhomocysteinemia

Journal

Arterial Hypertension

Issue

Vol 13, No 3 (2009)

Pages

167-174

Published online

2009-05-11

Bibliographic record

Nadciśnienie tętnicze 2009;13(3):167-174.

Keywords

hypertension
endothelium
C-reactive protein
homocysteine

Authors

Aleksandra Baszczuk
Zygmunt Kopczyński
Danuta Pupek-Musialik
Małgorzata Czeryba
Jarosław Kopczyński
Maciej Cymerys
Anna Thielemann

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl